Jump to main content
Jump to site search

All chapters
Previous chapter Next chapter

Section Editorial–Dermal Formulation Development

Since the mid-1990s, pharmaceutical R&D productivity has experienced what at best can be described as a downturn. From 1998 to 2008 the number of new molecular entities has been in general decline whereas attrition rates, development times and expenditure have all increased

Publication details


Print publication date
06 Dec 2013
Copyright year
2014
Print ISBN
978-1-84973-398-4
PDF eISBN
978-1-84973-463-9
From the book series:
Issues in Toxicology